No Data
No Data
Express News | Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for Gavreto® (Pralsetinib)
Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO (Pralsetinib)
Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE
Express News | Optime Care Expands Partnership With Rigel Pharmaceuticals to Include Commercial Distribution for Tavalisse®
Express News | Rigel Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Rigel Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)